Entero Healthcare Solutions (NSE:ENTERO) Debt-to-Equity: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
65 GF Score
Price ₹1,795.50
GF Value ₹1,618.63
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Debt-to-Equity?

Entero Healthcare Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹ Mil. Entero Healthcare Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹ Mil. Entero Healthcare Solutions's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹ Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Entero Healthcare Solutions's Debt-to-Equity or its related term are showing as below:

NSE:ENTERO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.21   Med: 0.4   Max: 0.84
Current: 0.4

During the past 6 years, the highest Debt-to-Equity Ratio of Entero Healthcare Solutions was 0.84. The lowest was 0.21. And the median was 0.40.

NSE:ENTERO's Debt-to-Equity is ranked better than
57.28% of 103 companies
in the Medical Distribution industry
Industry Median: 0.46 vs NSE:ENTERO: 0.40

Entero Healthcare Solutions  (NSE:ENTERO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Entero Healthcare Solutions Debt-to-Equity Related Terms

Entero Healthcare Solutions Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Debt-to-Equity Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial 0.63 0.73 0.21 0.22 0.39

Entero Healthcare Solutions Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.25 - 0.39 -

NSE:ENTERO vs MCK, COR, CAH: Debt-to-Equity Comparison

For the Medical Distribution subindustry, Entero Healthcare Solutions's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entero Healthcare Solutions Debt-to-Equity vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Entero Healthcare Solutions's Debt-to-Equity falls into.


NSE:ENTERO
65GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entero Healthcare Solutions Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Entero Healthcare Solutions's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(4722.13 + 2049.39) / 16886.1
=0.40

Entero Healthcare Solutions's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?

Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be overvalued. The current stock price of ₹1,795.50 is trading 10.9% above its estimated GF Value™ of ₹1,618.63. GuruFocus considers Entero Healthcare Solutions to be Modestly Overvalued.

Key valuation signals for NSE:ENTERO:

  • Debt-to-Equity:
  • GF Value™: ₹1,618.63 vs. price of ₹1,795.50 (10.9% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
65GF Score

Get the complete analysis for NSE:ENTERO

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,795.50
Price
₹1,618.63
GF Value